Prostate Cancer - Oncology Based Molecular Diagnostics Market Statistics
The global prostate cancer oncology based molecular diagnostics market size was valued at US$ 538.8 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 6% from 2024 to 2030.